Massachusetts Financial Services
BBIO icon

Massachusetts Financial Services’s BridgeBio Pharma BBIO Stock Holding History

Massachusetts Financial Services’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,231
Closed -$240K – 1010
2026
Q1 		$240K Sell
3,231
-84
-3% -$6.09K ﹤0.01% 934
2025
Q4 		$254K Buy
+3,315
New +$218K ﹤0.01% 903
2024
Q4 		– Sell
-737,367
Closed -$18.8M – 880
2024
Q3 		$18.8M Buy
737,367
+139,104
+23% +$3.65M 0.01% 600
2024
Q2 		$15.2M Buy
598,263
+219,257
+58% +$5.99M ﹤0.01% 605
2024
Q1 		$11.7M Buy
+379,006
New +$12.9M ﹤0.01% 615
2021
Q4 		– Sell
-441,288
Closed -$20.7M – 892
2021
Q3 		$20.7M Sell
441,288
-5,844
-1% -$313K 0.01% 611
2021
Q2 		$27.3M Sell
447,132
-1,285
-0.3% -$73.4K 0.01% 582
2021
Q1 		$27.6M Buy
448,417
+25,481
+6% +$1.67M 0.01% 573
2020
Q4 		$30.1M Buy
422,936
+7,811
+2% +$377K 0.01% 547
2020
Q3 		$15.6M Sell
415,125
-10,196
-2% -$321K 0.01% 592
2020
Q2 		$13.9M Buy
425,321
+32,613
+8% +$993K 0.01% 583
2020
Q1 		$11.4M Buy
392,708
+78,754
+25% +$2.44M 0.01% 576
2019
Q4 		$11M Buy
313,954
+96
+0% +$2.66K ﹤0.01% 592
2019
Q3 		$6.74M Sell
313,858
-36,142
-10% -$1,000K ﹤0.01% 638
2019
Q2 		$9.44M Buy
+350,000
New +$9.54M ﹤0.01% 628

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Massachusetts Financial Services's BBIO Position: Q2 2026 in Review

Massachusetts Financial Services sold out of BridgeBio Pharma (BBIO) in Q2 2026, closing a stake of 3,231 shares — an estimated $240K sold.

Massachusetts Financial Services first reported a position in BBIO in Q2 2019 and held it in 15 quarters. The position peaked at $30.1M in Q4 2020. 475 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Massachusetts Financial Services reported no remaining BridgeBio Pharma position as of Q2 2026 after selling out during the quarter.
  • Massachusetts Financial Services sold 3,231 BridgeBio Pharma shares in Q2 2026, an estimated $240K.
  • Massachusetts Financial Services first reported a position in BridgeBio Pharma in Q2 2019 and held it in 15 quarters.
  • Massachusetts Financial Services's BridgeBio Pharma position peaked at $30.1M in Q4 2020.
  • 475 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.